Cabot Corporation (CBT) P/E Ratio History
Historical price-to-earnings valuation from 1990 to 2026
Loading P/E history...
CBT Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Cabot Corporation (CBT) trades at a price-to-earnings ratio of 13.7x, with a stock price of $82.41 and trailing twelve-month earnings per share of $5.88.
The current P/E is 13% below its 5-year average of 15.8x. Over the past five years, CBT's P/E has ranged from a low of 8.9x to a high of 33.0x, placing the current valuation at the 60th percentile of its historical range.
Compared to the Basic Materials sector median P/E of 22.2x, CBT trades at a 38% discount to its sector peers. The sector includes 123 companies with P/E ratios ranging from 2.1x to 162.1x.
Relative to the broader market, CBT trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CBT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CBT P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 16.6 | 0.52Best | +229%Best | |
| $3B | 41.5 | 1.67 | +12% | |
| $835M | 14.0Lowest | 7.44 | +11% | |
| $25B | 16.1 | 1.75 | +46% | |
| $9B | 18.5 | 5.75 | -47% | |
| $13B | 19.1 | 1.06 | +17% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
CBT Historical P/E Data (1990–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | Wed Dec 31 2025 00:00:00 GM | $66.28 | $5.72 | 11.6x | -35% |
| FY2025 Q4 | $76.05 | $6.01 | 12.7x | -29% | |
| FY2025 Q3 | Mon Jun 30 2025 00:00:00 GM | $75.00 | $7.65 | 9.8x | -45% |
| FY2025 Q2 | Mon Mar 31 2025 00:00:00 GM | $83.14 | $7.73 | 10.8x | -39% |
| FY2025 Q1 | $91.31 | $7.98 | 11.4x | -35% | |
| FY2024 Q4 | Mon Sep 30 2024 00:00:00 GM | $111.77 | $7.19 | 15.5x | -12% |
| FY2024 Q3 | Sun Jun 30 2024 00:00:00 GM | $91.89 | $8.86 | 10.4x | -41% |
| FY2024 Q2 | Sun Mar 31 2024 00:00:00 GM | $92.20 | $8.35 | 11.0x | -38% |
| FY2024 Q1 | Sun Dec 31 2023 00:00:00 GM | $83.50 | $7.70 | 10.8x | -39% |
| FY2023 Q4 | Sat Sep 30 2023 00:00:00 GM | $69.27 | $7.75 | 8.9x | -50% |
| FY2023 Q3 | Fri Jun 30 2023 00:00:00 GM | $66.89 | $5.30 | 12.6x | -29% |
| FY2023 Q2 | Fri Mar 31 2023 00:00:00 GM | $76.64 | $5.58 | 13.7x | -22% |
Average P/E for displayed period: 17.7x
See CBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CBT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CBT vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonCBT — Frequently Asked Questions
Quick answers to the most common questions about buying CBT stock.
Is CBT stock overvalued or undervalued?
CBT trades at 13.7x P/E, near its 5-year average of 15.8x. The 60th percentile ranking places valuation within normal historical bounds.
How does CBT's valuation compare to peers?
Cabot Corporation P/E of 13.7x compares to sector median of 22.2x. The discount suggests lower growth expectations or higher risk.
What is CBT's PEG ratio?
CBT PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1990-2026.